Correlation Between Entera Bio and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both Entera Bio and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entera Bio and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entera Bio and Tempest Therapeutics, you can compare the effects of market volatilities on Entera Bio and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entera Bio with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entera Bio and Tempest Therapeutics.
Diversification Opportunities for Entera Bio and Tempest Therapeutics
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Entera and Tempest is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Entera Bio and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Entera Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entera Bio are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Entera Bio i.e., Entera Bio and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between Entera Bio and Tempest Therapeutics
Given the investment horizon of 90 days Entera Bio is expected to under-perform the Tempest Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Entera Bio is 1.63 times less risky than Tempest Therapeutics. The stock trades about -0.21 of its potential returns per unit of risk. The Tempest Therapeutics is currently generating about -0.12 of returns per unit of risk over similar time horizon. If you would invest 110.00 in Tempest Therapeutics on August 29, 2024 and sell it today you would lose (16.00) from holding Tempest Therapeutics or give up 14.55% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Entera Bio vs. Tempest Therapeutics
Performance |
| Timeline |
| Entera Bio |
| Tempest Therapeutics |
Entera Bio and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Entera Bio and Tempest Therapeutics
The main advantage of trading using opposite Entera Bio and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entera Bio position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.| Entera Bio vs. NLS Pharmaceutics AG | Entera Bio vs. Vaccinex | Entera Bio vs. Alterity Therapeutics | Entera Bio vs. Immutep Ltd ADR |
| Tempest Therapeutics vs. Indaptus Therapeutics | Tempest Therapeutics vs. Rezolute | Tempest Therapeutics vs. Forte Biosciences | Tempest Therapeutics vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |